Cargando…

Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia

Detalles Bibliográficos
Autores principales:	Zurita‐Lizza, Christian Carlos, Doreski, Pablo Alexis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087023/ https://www.ncbi.nlm.nih.gov/pubmed/35572363 http://dx.doi.org/10.1002/ctd2.31

Ejemplares similares

“Mosaic Perfusion Pattern” on Dual-Energy CT in COVID-19 Pneumonia: Pulmonary Vasoplegia or Vasoconstriction?
por: Jain, Amit, et al.
Publicado: (2020)

Ketamine, Interleukin-6, and Vasoplegia: Is Prevention the Best Medicine?
por: Ortoleva, Jamel P.
Publicado: (2023)

Vasoplegia during radical prostatectomy: Methylene blue to rescue
por: Manish, Tandon, et al.
Publicado: (2023)

Vasoplegia: A Review
por: Ratnani, Iqbal, et al.
Publicado: (2023)

Rapid reversal of vasoplegia with methylene blue in calcium channel blocker poisoning
por: Saha, Biplab K., et al.
Publicado: (2020)

The Durability of Intravenous Hydroxocobalamin in Vasoplegia
por: Blaha, Madeline, et al.
Publicado: (2023)

Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment
por: Barbosa Evora, Paulo Roberto
Publicado: (2018)

Ibuprofen-Induced Renal Tubular Acidosis
por: Watanabe, Toru
Publicado: (2018)

Vasoplegia treatments: the past, the present, and the future
por: Levy, Bruno, et al.
Publicado: (2018)

Interactions between ibuprofen, ACE2, renin‐angiotensin system, and spike protein in the lung. Implications for COVID‐19
por: Valenzuela, Rita, et al.
Publicado: (2021)

Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass
por: Pasero, D., et al.
Publicado: (2020)

Vasoplegia: Mechanism and Management Following Cardiopulmonary Bypass
por: Muhammad, Rizal, et al.
Publicado: (2022)

Non-Pigmented Fixed Drug Eruption Caused by Ibuprofen
por: Singhal, Rochit R., et al.
Publicado: (2019)

Pulmonary Fibrosis Due to COVID-19 Pneumonia
por: Kayhan, Servet, et al.
Publicado: (2020)

Allergen inhalation challenge, refractoriness and the effects of ibuprofen
por: Nomani, Shawn, et al.
Publicado: (2016)

Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms
por: Burgdorff, A.-M., et al.
Publicado: (2018)

The Use of Methylene Blue during Liver Transplantation for Vasoplegia
por: Harding, Paul, et al.
Publicado: (2021)

Commentary: Vasoplegia after aortic surgery: Looking for options
por: Serna-Gallegos, Derek, et al.
Publicado: (2020)

Regarding “Pulmonary Vascular Manifestations of COVID-19 Pneumonia”
por: Balestrieri, Antonella
Publicado: (2020)

No arguments for extra risk from ibuprofen in SARS-COV2 infection
por: Moore, Nicholas
Publicado: (2020)

Feasibility and Initial Safety Evaluation of Inhaled (13)C-Urea in Ambulatory Patients with Pneumonia
por: Baca, Justin T., et al.
Publicado: (2022)

COVID-19 and molecular hydrogen inhalation
por: Ostojic, Sergej M.
Publicado: (2020)

Ibuprofen-induced Kounis syndrome with diffuse ST segment depression and atrial fibrillation
por: Akçay, Murat
Publicado: (2017)

Pulmonary metastases of lung adenocarcinoma mimicking COVID-19 pneumonia
por: Shiroyama, Takayuki, et al.
Publicado: (2020)

How Much has COVID-19 Contributed to Increase the Worldwide Consumption of Paracetamol and Ibuprofen? Evidence From an Infodemiological Analysis
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

High-Dose Hydroxocobalamin for Refractory Vasoplegia Post Cardiac Surgery
por: Bak, Marek A, et al.
Publicado: (2022)

The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia
por: Papazisi, Olga, et al.
Publicado: (2020)

COVID-19-associated acute respiratory distress syndrome (C-ARDS): Inhaled nitroglycerin could be an efficient pulmonary vasodilator
por: Daunaria, Deepak K., et al.
Publicado: (2023)

Pulmonary rehabilitation in post-discharge treatment of patients with COVID-19 pneumonia
por: Bi, Yueyang, et al.
Publicado: (2022)

Recovery of exercise capacity after COVID-19 pneumonia: Key role of right ventricular-pulmonary circulation unit: The role of pulmonary vasculature in exercise after COVID-19 pneumonia
por: Rinaldo, R.F., et al.
Publicado: (2022)

Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
por: Asakura, Hidesaku, et al.
Publicado: (2020)

Delayed pulmonary abscess following COVID-19 pneumonia: A case report
por: Renaud-Picard, B., et al.
Publicado: (2020)

Comment on: Evaluation of pulmonary function and exercise capacity after COVID-19 pneumonia
por: Islam, Hamza, et al.
Publicado: (2023)

Comment on: Evaluation of pulmonary function and exercise capacity after COVID-19 pneumonia
por: Llerena-Velastegui, Jordan, et al.
Publicado: (2023)

Comment on an article: “High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia”
por: Ibrahimagić, Omer Ć., et al.
Publicado: (2020)

The reversed halo sign: also think about chronic eosinophilic pneumonia
por: Rea, Gaetano, et al.
Publicado: (2017)

Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation
por: Tecson, Kristen M., et al.
Publicado: (2018)

Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting
por: Sovic, William, et al.
Publicado: (2021)

Commentary: Angiotensin II for vasoplegia: A desperate measure for desperate times
por: Balsam, Leora B.
Publicado: (2020)

Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia
por: Ayasa, Laith A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_64h0edn9h7nndbch12ufl45c5a